JMJD2C/KDM4C interacts with HIF1A to enhance target gene activation and promote breast cancer progression and metastasis by demethylating H3 lysine 9 near several HIF1A target genes (Luo et al., 2012). Here, KDM4C is linked to breast carcinoma.